Nitroglycerine a Possible Treatment Protocol for Prostate Cancer

Advanced Prostate Cancer 2/6/10 10:31 AM Joel Clinical Trials Drugs and Treatments On The Horizon Uncategorized Joel T Nowak Malecare nitroglycerin PSA recurrence Comments

In a clinical trial conducted at Queen’s University, Canada, researchers, Robert Siemens, Jeremy Heaton, Michael Adams, Jun Kawakami and Charles Graham, have found that nitroglycerin, the widely used explosive which is also commonly used to treat angina, can treat prostate cancer. The researchers found that very low doses of nitroglycerin slow the growth or even stop the progression of prostate cancer without the severe side effects we experience from current treatments.
The researchers based the trial on pre-clinical research carried out at Queen’s where they found that nitric oxide plays an important role in prostate tumor progression and low-dose nitroglycerin is capable of controlling this process.
The researchers used low doses of nitroglycerin in a 24-month, phase II study, involving 29 men who had increasing levels of prostate-specific antigen (PSA) following prostate surgery or radiation (PSA only recurrences). The men in the trial were treated with a low-dose, slow-release nitroglycerin skin patches known as NOVade. The pharmaceutical company, Nometics Inc. of Canada, developed the skin patches.
Of the 17 men who completed the study, all but one showed a stabilization or decrease in the rate of cancer progression, as measured by their PSA Doubling Time. There wasn’t any information presented about why 7 of the subject men failed to complete the study.
The trial results appeared in a recent issue of the journal Urology. In the journal they stated that, “We were very excited to see a significant slowing in the progression of the disease as evidenced by the men’s PSA levels, and to see this result in many of the men who completed the study.”
The potential for these findings could be significant and far reaching as nitroglycerin is inexpensive, has already demonstrated that it is safe and has already approved by the FDA. After additional confirmation studies, nitroglycerin patches could easily be prescribed as an “off label” and relatively benign treatment for recurrent prostate cancer. Nitroglycerin, perhaps a treatment on the horizon.
Joel T Nowak, MA, MSW


About The Success Architect®️

Business Owner | Business Advisor | Cancer survivor, Class of 2003 | Founder and President of the Cancer Journeys Foundation | Founder of the Tour de USA®️ to End Cancer | Founder and CEO of The Success Foundry | Best Selling Author | Speaker | Senior Fellow @ the Center for the Digital Future USC Annenberg School |Business Coach Founder, CEO of TSG Inc | Founder and Partner of InterSpaceLA | Thought Partner | Founder of Pony Express Riders | Autocrosser | Motorcycle Rider | Bicycle Racer | USA Cycling Coach | Retired career Army officer | Prostate Cancer Advocate | Find me at
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s